论文部分内容阅读
经皮射频热凝术(Percutaneous radiotrequencythermocoagulation,PRTC)治疗原发性三叉神经痛在国外开展30年,在国内开展20年,虽未能广泛应用,但技术日趋成熟,积累了一些经验。面对4/10万发病率众多的本病患者,我们近3年半用该法治疗60例,现予以总结。资料与方法一般资料男16例,女44例;年龄31~83岁,平均63岁;病程3个月~28年,平均9.4年;颅底 X线平片或头颅 CT 检查60例,除少数年老者示恼老化和无临床症状的腔梗外,余均正常。术前都做血常规及出凝血检验,少数存在颗粒白细胞和血小板减少,余结果正常。
Percutaneous radiofrequency thermocoagulation (PRTC) for the treatment of primary trigeminal neuralgia in foreign countries for 30 years, 20 years in the country, although not widely used, but the technology is maturing and accumulated some experience. The face of 4/10 million patients with a high incidence of this disease, we nearly 60 years of treatment with the law in the past three and a half, are summarized. Materials and Methods General information 16 males and 44 females; aged 31 to 83 years, mean 63 years; duration of 3 months to 28 years, an average of 9.4 years; skull base X-ray or CT skull 60 cases, except for a few Elderly people show no signs of aging and no clinical symptoms of lumen, I were normal. Preoperative blood tests are done and a coagulation test, a small number of particles of white blood cells and thrombocytopenia, the remaining results were normal.